Schedule 13G ownership disclosure

Y-MABS THERAPEUTICS INC

Security class unavailable · CUSIP: 984241109

Event date: 2021-06-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,448,610
Percent of class
10.2100%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902219-21-000376
Form type
SC 13G/A
Filer
WELLINGTON MANAGEMENT GROUP LLP
CIK
CIK 902219
Filed
Jul 12, 2021
Reporting period
Jun 30, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub